middle.news
Patrys Locks in 50% Revenue Share on Deoxymab IP with Yale Deal
8:22am on Monday 13th of July, 2026 AEST
•
Healthcare
Read Story
Patrys Locks in 50% Revenue Share on Deoxymab IP with Yale Deal
8:22am on Monday 13th of July, 2026 AEST
Key Points
50% revenue share from Yale on deoxymab IP
IP assigned to university-backed start-up for development
Patrys reduces capital outlay but retains upside exposure
Ongoing clinical research collaborations continue
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Patrys (ASX:PAB)
OPEN ARTICLE